At the annual state of Stanford Medicine address, leaders unveiled plans to refresh the integrated strategic plan and to continue implementing the Commission on Justice and Equity’s recommendations.

Developing the right treatment for long COVID depends on figuring out what’s causing it. Stanford Medicine researchers are bent on learning more about the people who have it to find out.

Researchers were able to devise an app that can determine which skin lesions are caused by mpox with an accuracy of 90%.

Using pulses of light to control heart rate, Stanford Medicine researchers investigate a long-standing mystery about how physical states influence emotions.

Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.

A statewide quality-improvement project to treat excessive bleeding during childbirth averts $9 million annually in California’s health care costs, a Stanford Medicine-led study found.

The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.

A genetic risk factor found virtually exclusively among people of at least partial African ancestry substantially boosts the risk of incurring Alzheimer’s disease — but only sometimes.

Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.

When mice watch other mice brawl, neurons in their brains fire as if they’re in the fight, according to a new study by Stanford Medicine researchers.

Stanford Medicine scientists and their colleagues have shown they can tap mothers’ and babies’ medical records to better predict newborn health risks.

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.